Fortress Biotech, Inc.

FBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007
Operating Activities
Net Income $-3.7M $-3.8M $-2.6M
Depreciation & Amortization
Depreciation $5.0K
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-2.4M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $-2.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $3.9M
Net Change in Cash $1.5M
Free Cash Flow
← Newer Page 3 of 3 Older →